These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1357919)

  • 21. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas.
    el-Azouzi M; Chung RY; Farmer GE; Martuza RL; Black PM; Rouleau GA; Hettlich C; Hedley-Whyte ET; Zervas NT; Panagopoulos K
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7186-90. PubMed ID: 2571151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity for alleles on chromosome 10 in human brain tumours.
    Ye Z; Qu JK; Darras BT
    Neurol Res; 1993 Feb; 15(1):59-62. PubMed ID: 8098856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR; Pu PY; Mohamed AN; Galicich JH; Ebrahim SA; Shapiro WR
    Cancer; 1993 Jun; 71(12):4007-21. PubMed ID: 8389658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
    Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression.
    Oskam NT; Bijleveld EH; Hulsebos TJ
    Int J Cancer; 2000 Feb; 85(3):336-9. PubMed ID: 10652423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Hoell T; Chung RY; Martuza RL; Schoenfeld DA; Yaşargil MG; Wiestler OD
    J Neurosurg; 1992 Aug; 77(2):295-301. PubMed ID: 1320666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TP53 gene mutations and 17p deletions in human astrocytomas.
    Chung R; Whaley J; Kley N; Anderson K; Louis D; Menon A; Hettlich C; Freiman R; Hedley-Whyte ET; Martuza R
    Genes Chromosomes Cancer; 1991 Sep; 3(5):323-31. PubMed ID: 1686725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Instability of microsatellites in human gliomas.
    Dams E; Van de Kelft EJ; Martin JJ; Verlooy J; Willems PJ
    Cancer Res; 1995 Apr; 55(7):1547-9. PubMed ID: 7882363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deletion mapping of chromosome 19 in human gliomas.
    von Deimling A; Nagel J; Bender B; Lenartz D; Schramm J; Louis DN; Wiestler OD
    Int J Cancer; 1994 Jun; 57(5):676-80. PubMed ID: 8194874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion mapping of the long arm of chromosome 10 in glioblastoma multiforme.
    Fults D; Pedone C
    Genes Chromosomes Cancer; 1993 Jul; 7(3):173-7. PubMed ID: 7687872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme.
    Fujimoto M; Fults DW; Thomas GA; Nakamura Y; Heilbrun MP; White R; Story JL; Naylor SL; Kagan-Hallet KS; Sheridan PJ
    Genomics; 1989 Feb; 4(2):210-4. PubMed ID: 2544511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic alterations associated with glioma progression.
    Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
    Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amplification of the anonymous marker D17S67 in malignant astrocytomas.
    Bijlsma EK; Leenstra S; Westerveld A; Bosch DA; Hulsebos TJ
    Genes Chromosomes Cancer; 1994 Feb; 9(2):148-52. PubMed ID: 7513547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progression-associated gene regions in astrocytomas: a candidate locus on chromosome 19q].
    von Deimling A; Albrecht S; Wiestler OD
    Verh Dtsch Ges Pathol; 1994; 78():423-6. PubMed ID: 7534013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.